---
$id: https://graph.org.ai/products/commodity/51241244
$type: Product
source: UNSPSC
code: "51241244"
title: "Etretinate"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etretinate

**UNSPSC Code**: 51241244
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a retinoic acid agent with the molecular formula C23H30O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65M2UDR9AG, chemically known as ethyl 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraenoate but generally known as etretinate, which bears US NIH Compound Identifier 3312. European Medicines Agency schedules Etretinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07346MIG. The term ETRETINATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules etretinate in its Anatomical Therapeutic Chemical (ATC) Classification. ETRETINATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etretinate under HS 29189900 and SITC 51396. As of Q4 2014, ETRETINATE remains the US FDA Preferred Term for this commodity. Etretinate bears US NLM identifiers UMLS ID C0015137 and NCI Concept Code C29036. SMILES: O(C1C(C(C(C(C1)C)/C=C/C(=C/C=C/C(=C/C(=O)OCC)C)C)C)C)C.

